SCHEMBL6270731

SCHEMBL6270731

CCCCCCCCOc1c(O)c2cccc(OCCCO)c2oc1=O

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 8/20 0.43
LTB4R Q15722 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NR1I2 O75469 1/20 0.39
LMNA P02545 1/20 0.39
CHRM2 P08172 1/20 0.39
CYP3A4 P08684 1/20 0.39
ADRA2A P08913 1/20 0.39
MAPT P10636 1/20 0.39
OPRK1 P41145 1/20 0.39
HTR2B P41595 1/20 0.39
SLC6A3 Q01959 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
CNR1 P21554 3/20 0.39
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6275183 1.00 CNR2 (0.43) CNR2LTB4RMEN1KMT2ANR1I2
SCHEMBL27599580 1.00 CNR2 (0.43) CNR2LTB4RMEN1KMT2ANR1I2
SCHEMBL6277175 0.98 CNR2 (0.43) CNR2LTB4RMEN1KMT2ANR1I2
SCHEMBL6276200 0.98 CNR2 (0.43) CNR2LTB4RMEN1KMT2ANR1I2
SCHEMBL6275622 0.95 CNR2 (0.43) CNR2LTB4RMEN1KMT2ANR1I2
SCHEMBL6276238 0.95 CNR2 (0.43) CNR2LTB4RMEN1KMT2ANR1I2
SCHEMBL6276043 0.95 CNR2 (0.43) CNR2LTB4RMEN1KMT2ANR1I2
SCHEMBL6277139 0.95 CNR2 (0.43) CNR2LTB4RMEN1KMT2ANR1I2
SCHEMBL6276187 0.95 CNR2 (0.47) CNR2MEN1KMT2ALMNAMAPT
SCHEMBL8497264 0.95 CNR2 (0.46) CNR2LTB4RMEN1KMT2ANR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1273578-B1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK & CHEMICALS (JP) 2005-02-23 EP disclosed
CN-1473565-A Benzopyrany/derivatives and antiallergic agent ���ձ���ī��ѧ��ʽ���� 2004-02-11 CN disclosed
US-6670391-B2 For inhibiting both immediate and delayed type allergic reactions; side effect reduction DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-12-30 US disclosed
US-20030096860-A1 Benzopyran derivative and antiallergic agent DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-05-22 US disclosed
EP-1273578-A1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096860-A1 Benzopyran derivative and antiallergic agent HRH2, HRH1, HRH4 CNR2 249/4885LTB4R 107/4885MEN1 4691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.